Fetal Neuroprotection and Neuroplasticity Program
Scientists know that heart disease can impact a baby’s brain development while they are in the womb. The most common complication of congenital heart disease (CHD) is neurodevelopmental disability, which can lead to long-term problems with learning, attention, motor skills, speech and language, social interaction, vision and hearing.
Most studies of treatments to prevent this type of brain injury focus on what happens after a baby is born. Our Fetal Neuroprotection and Neuroplasticity Program at Children's Hospital of Philadelphia (CHOP) is dedicated to the discovery of new prenatal treatments that will protect brain development and prevent brain injury as early as possible before birth.
How we serve you
Our program is a joint effort of the Cardiac Center, the Fetal Heart Program, the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment and the Division of Neurology. Together, we are committed to improving the long-term quality of life for children born with CHD and other birth defects (also called congenital anomalies) associated with neurodevelopmental delays. Our goal is to uncover the cause of this abnormal brain development and discover new treatments to prevent it.
Meet your team
Our multidisciplinary team is committed to ongoing research that will improve the health and well-being of your child, and all children with heart disease.
Our research
We are involved in clinical trials of new prenatal treatments to learn whether they can lower the risk of brain injury and improve brain development in newborns with CHD and other congenital anomalies. Each study has its own specific requirements. Please call us if you are interested in participating.
Events
Cardiology 2025
Wednesday, Feb 19, 2025
Philly Spin-In
Saturday, Mar 08, 2025
Your donation changes lives
Every donation helps us make lifesaving breakthroughs for children everywhere.